Page 19 - Sanket Koul

CDSCO revises export NOC rules for new drugs; sets one-year validity

New CDSCO rules set one-year validity for export NOCs, fix seven-day timeline, and simplify process for unapproved and approved drugs meant solely for export

PB Health raises $218 mn in seed round led by US-based General Catalyst

PB Health, the healthcare venture of PB Fintech, has raised $218 million to set up a 1,000-bed hospital network in Delhi NCR and drive health-tech innovation

Tribeca eyes 8-12 projects in 3 years under new plotted housing arm

Tribeca launches a new vertical, Tribeca Estates, to focus on plotted developments, luxury villas, and hospitality-led townships across key Indian cities

NPPA fixes retail prices of 84 drugs, including empagliflozin combos

The NPPA has fixed retail prices for 84 drug formulations, including 36 combinations of off-patent diabetes drug empagliflozin, after a steep drop in prices

Cabinet approves Rs 11,829-cr expansion of five IITs, 6,576 new seats added

The expansion plan covers IITs in Bhilai, Dharwad, Jammu, Palakkad and Tirupati, adding 6,576 seats and 130 faculty posts with full implementation by FY29

India's pharma market grows 7.8% in April, led by chronic therapies

Chronic therapies and price increases drove 7.8 per cent growth in India's pharma market in April 2025, with cardiac and gastrointestinal segments showing double-digit value gains

Poly Medicure Q4 results: Profit rises 34% on strong exports, new divisions

Poly Medicure posted a 34 per cent rise in Q4 net profit to Rs 91.8 crore, with revenue up 16.6 per cent, driven by strong export performance and new business verticals

Schedule M rollout may face delay as MSMEs seek more time for upgrade

Small drugmakers seek a three-month extension to submit GMP compliance plans under revised Schedule M, raising concerns about delays in national rollout

Pristyn Care opens 3 hospitals in NCR, targets 50 by FY28 public listing

Healthtech firm Pristyn Care moves from asset-light model to hospital ownership, aiming for 50 hospitals, Rs 2,000 crore revenue and 20% Ebitda by FY28 IPO

Oswal Group to invest ₹1,350 crore in Punjab realty over next 3 years

Vardhman Amrante to invest ₹1,350 crore in Punjab, developing commercial spaces and integrated residences in Ludhiana and Bhatinda through internal accruals and sales

MedTech multinationals bet big on India, eyeing global hub status

Global medtech giants like Siemens and Philips are expanding R&D and manufacturing in India, leveraging policy support and talent to embed India in global value chains

Doctors, drugmakers divided over SC's prescribe-only-generics remark

The SC's suggestion to mandate generic-only prescriptions has drawn mixed reactions from the medical and pharma community, highlighting concerns over quality and feasibility

Scorching weather in North India drives rise in heat-related illnesses

Govt, hospitals preparing to make necessary arrangements to tackle increased heatwave load

DLF plans luxury highrise project with over 1,000 apartments in Gurugram

This comes after the firm had sold out two earlier launched projects - Privana South and Privana West - with 1,113 units and 795 units, respectively

IIT-BHU signs MoU with Saras institute to offer foundation course in AI

Through this MoU, Saras will offer its foundational eight-week AI course as an open elective for IIT-BHU students

Houses delivered in 9 major Indian cities up 33% in FY25: Report

Western and Southern markets report surge, trend expected to continue

Max Healthcare plans to expand bed capacity by at least 30% in FY26

Company inaugurates 300-bed greenfield hospital in Delhi's Dwarka, aims to invest ₹6,500 cr by FY28

Indian universities tailor curriculum for students seeking foreign degrees

Visa worry, rising costs making Indian students consider alternatives closer home

NTA launches platform for candidates to report suspicious claims on NEET-UG

Seen as a precautionary measure, the platform launch comes after several irregularities such as cheating, impersonation and paper leak were alleged in last year's exam

Booster dose: India inches closer to regulatory framework for OTC drugs

DTAB has accepted sub-panel recommendation on OTC drugs list